Risk-adapted therapy for the management of cytokine release syndrome in children undergoing unmanipulated haploidentical stem cell transplantation.

MLA

Jayakumar, Indira, et al. “Risk-Adapted Therapy for the Management of Cytokine Release Syndrome in Children Undergoing Unmanipulated Haploidentical Stem Cell Transplantation.” Pediatric Transplantation, vol. 25, no. 5, Aug. 2021, p. e13964. EBSCOhost, https://doi.org/10.1111/petr.13964.

APA

Jayakumar, I., Uppuluri, R., Lakshmanan, C., Kumar Gowdhaman, A., Vellaichamy Swaminathan, V., & Raj, R. (2021). Risk-adapted therapy for the management of cytokine release syndrome in children undergoing unmanipulated haploidentical stem cell transplantation. Pediatric Transplantation, 25(5), e13964. https://doi.org/10.1111/petr.13964

Chicago

Jayakumar, Indira, Ramya Uppuluri, Chidhambharam Lakshmanan, Anand Kumar Gowdhaman, Venkateswaran Vellaichamy Swaminathan, and Revathi Raj. 2021. “Risk-Adapted Therapy for the Management of Cytokine Release Syndrome in Children Undergoing Unmanipulated Haploidentical Stem Cell Transplantation.” Pediatric Transplantation 25 (5): e13964. doi:10.1111/petr.13964.